Skip to content

Grand Roundup: Top posts for the week of Oct. 28

The five most-read stories on Scope this week were:

The mystery surrounding lung-transplant survival rates: A recent story in the San Francisco Chronicle takes a closer look at the challenges facing lung transplant patients and explores why a significant number don’t live beyond the five-year mark, despite improvements in survival rates.

From frustration to foundation: Embracing a diagnosis of celiac disease: Inspire contributor Alice Bast shares her empowering story of living with celiac disease and reveals why the day she was diagnosed with the autoimmune disorder was the best day of her life.

Ask Stanford Med: Answers to your questions about seasonal influenzaCorry Dekker, MD, medical director of the Stanford-Lucile Packard Children’s Hospital Vaccine Program, responds to your questions about the flu and vaccine research in this month's installment of the Ask Stanford Med series.

In Stanford/Gladstone study, yeast genetics further ALS research: Researchers at Stanford and San Francisco’s Gladstone Institutes have used baker’s yeast — a tiny, one-celled organism — to identify a chink in the armor of amyotrophic lateral sclerosis, also called Lou Gehrig’s disease. The findings may eventually lead to new therapies for human patients.

Stanford study on the health benefits of organic food: What people are saying: A collection of reactions from journalists and sources featured in various articles in response to Stanford researchers’ recent study on the health benefits of organic foods.

Popular posts

Category:
Genetics
Sex biology redefined: Genes don’t indicate binary sexes

The scenario many of us learned in school is that two X chromosomes make someone female, and an X and a Y chromosome make someone male. These are simplistic ways of thinking about what is scientifically very complex.
Category:
Nutrition
Intermittent fasting: Fad or science-based diet?

Are the health-benefit claims from intermittent fasting backed up by scientific evidence? John Trepanowski, postdoctoral research fellow at the Stanford Prevention Research Center,weighs in.